New York State Common Retirement Fund’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8
Closed -$525 3195
2024
Q2
$525 Sell
8
-537
-99% -$63.9K ﹤0.01% 3334
2024
Q1
$93.8K Sell
545
-1
-0.2% -$124 ﹤0.01% 2772
2023
Q4
$67.2K Sell
546
-2
-0.4% -$173 ﹤0.01% 2904
2023
Q3
$46.6K Buy
548
+10
+2% +$1.27K ﹤0.01% 3043
2023
Q2
$80.7K Buy
+538
New +$92.5K ﹤0.01% 2999
2022
Q3
Sell
-5
Closed -$1K 3279
2022
Q2
$1K Sell
5
-202
-98% -$32.1K ﹤0.01% 3320
2022
Q1
$52K Hold
207
﹤0.01% 3159
2021
Q4
$203K Buy
207
+36
+21% +$46K ﹤0.01% 2871
2021
Q3
$251K Sell
171
-53
-24% -$103K ﹤0.01% 2823
2021
Q2
$474K Buy
224
+88
+65% +$199K ﹤0.01% 2619
2021
Q1
$346K Buy
+136
New +$349K ﹤0.01% 2630

Other funds holding BCAB

New York State Common Retirement Fund's BCAB Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of BioAtla (BCAB) in Q3 2024, closing a stake of 8 shares — an estimated $525 sold.

New York State Common Retirement Fund first reported a position in BCAB in Q1 2021 and held it in 11 quarters. The position peaked at $474K in Q2 2021. 63 funds tracked by Wall St. Rank hold BCAB as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining BioAtla position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 8 BioAtla shares in Q3 2024, an estimated $525.
  • New York State Common Retirement Fund first reported a position in BioAtla in Q1 2021 and held it in 11 quarters.
  • New York State Common Retirement Fund's BioAtla position peaked at $474K in Q2 2021.
  • 63 funds tracked by Wall St. Rank held BioAtla as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.